Загрузка...

Saving cognitive outcome data in Alzheimer's disease clinical trials during the COVID‐19 pandemic: Commentary on the virtual administration of the ADAS‐Cog

Elderly participants in Alzheimer's disease (AD) clinical trials are at high risk of morbidity and mortality with interpersonal exposure to COVID‐19, a situation that is likely to continue for the foreseeable future. Yet, in‐person neuropsychological assessments remain the mainstay primary outc...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Alzheimers Dement (N Y)
Главные авторы: Schwab, Nadine A., DesRuisseaux, Libby A., Weinberg, Marc S., Arnold, Steven E.
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2020
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7744007/
https://ncbi.nlm.nih.gov/pubmed/33344748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/trc2.12081
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!